Form 8-K - Current report:
SEC Accession No. 0001493152-24-023859
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:16
Documents
15
Period of Report
2024-06-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40937
2 ex99-1.htm EX-99.1 231337
3 ex99-1_001.jpg GRAPHIC 3567
  Complete submission text file 0001493152-24-023859.txt   459681

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pure-20240614.xsd EX-101.SCH 3012
5 XBRL LABEL FILE pure-20240614_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pure-20240614_pre.xml EX-101.PRE 22357
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3281
Mailing Address 771 JAMACHA ROAD #512 EL CAJON CA 92019
Business Address 771 JAMACHA ROAD #512 EL CAJON CA 92019 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-14468 | Film No.: 241044685
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)